NCT07024914View on ClinicalTrials.gov

Effect of Oxygen Supplementation on Cerebral Oxygenation, Symptoms and Performance During STST in COPD Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Oxygen

Oxygen supplementation via nasal cannula at a rate of 3 lit/min during 30sec Sit-To-Stand Test among COPD patients without resting hypoxemia

DRUG

medical air

Medical Air supplementation via nasal cannula at a rate of 3 lit/min during 30sec Sit-To-Stand Test among COPD patients without resting hypoxemia

Trial Locations (1)

57010

Papanikolaou General Hospital, Thessaloniki

All Listed Sponsors
lead

George Papanicolaou Hospital

OTHER

NCT07024914 - Effect of Oxygen Supplementation on Cerebral Oxygenation, Symptoms and Performance During STST in COPD Patients | Biotech Hunter | Biotech Hunter